Comparative Study
doi: 10.1016/j.ajo.2009.04.010.
The as-needed treatment strategy for choroidal neovascularization: a feedback-based treatment system
- PMID: 19540983
- DOI: 10.1016/j.ajo.2009.04.010
Item in Clipboard
Comparative Study
The as-needed treatment strategy for choroidal neovascularization: a feedback-based treatment system
Am J Ophthalmol.
2009 Jul.
No abstract available
Comment on
-
Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: the second year of a prospective study.Am J Ophthalmol. 2009 Jul;148(1):59-65.e1. doi: 10.1016/j.ajo.2009.02.006. Epub 2009 Apr 18. Am J Ophthalmol. 2009. PMID: 19375689 Clinical Trial.
-
A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.Am J Ophthalmol. 2009 Jul;148(1):43-58.e1. doi: 10.1016/j.ajo.2009.01.024. Epub 2009 Apr 18. Am J Ophthalmol. 2009. PMID: 19376495 Clinical Trial.
Similar articles
-
Intravitreal bevacizumab.Ophthalmology. 2007 Feb;114(2):400; author reply 400-1. doi: 10.1016/j.ophtha.2006.10.002. Ophthalmology. 2007. PMID: 17270701 No abstract available.
-
Intravitreal bevacizumab for parapapillary choroidal neovascularization due to exudative age-related macular degeneration.Acta Ophthalmol. 2011 Feb;89(1):e105-7. doi: 10.1111/j.1755-3768.2009.01820.x. Acta Ophthalmol. 2011. PMID: 20064119 No abstract available.
-
Comparing ranibizumab with bevacizumab.Ophthalmology. 2011 Mar;118(3):600-600.e2. doi: 10.1016/j.ophtha.2010.10.027. Ophthalmology. 2011. PMID: 21376243 Clinical Trial. No abstract available.
-
Avastin and new treatments for AMD: where are we?Retina. 2006 Oct;26(8):853-8. doi: 10.1097/01.iae.0000244722.35073.7c. Retina. 2006. PMID: 17031283 Review. No abstract available.
-
Position paper: the need for head-to-head studies comparing Avastin versus Lucentis.Surv Ophthalmol. 2009 Nov-Dec;54(6):705-7. doi: 10.1016/j.survophthal.2009.08.002. Surv Ophthalmol. 2009. PMID: 19818262 Review. No abstract available.
Cited by
-
Patient-reported outcome measures in the management of neovascular age-related macular degeneration: a 1-year prospective study.BMJ Open Ophthalmol. 2019 Oct 3;4(1):e000353. doi: 10.1136/bmjophth-2019-000353. eCollection 2019. BMJ Open Ophthalmol. 2019. PMID: 31673632 Free PMC article.
-
Comparison of Two Different Treat-and-Extend Protocols with Aflibercept in Wet Age-Related Macular Degeneration: Two-Year Results.Adv Ther. 2020 May;37(5):2256-2266. doi: 10.1007/s12325-020-01312-2. Epub 2020 Apr 10. Adv Ther. 2020. PMID: 32277343 Clinical Trial.
-
A delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration.J Ophthalmol. 2014;2014:595132. doi: 10.1155/2014/595132. Epub 2014 Dec 21. J Ophthalmol. 2014. PMID: 25587438 Free PMC article.
-
Ranibizumab for exudative AMD in a clinical setting: differences between 2007 and 2010.Graefes Arch Clin Exp Ophthalmol. 2013 Nov;251(11):2499-503. doi: 10.1007/s00417-013-2338-z. Epub 2013 Apr 19. Graefes Arch Clin Exp Ophthalmol. 2013. PMID: 23604514
-
Long-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation.Br J Ophthalmol. 2010 Jun;94(6):701-5. doi: 10.1136/bjo.2009.167627. Epub 2009 Oct 23. Br J Ophthalmol. 2010. PMID: 19854733 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
